As previous report have shown that p5365-73 peptide (RMPEAAPPV) is an HLA-A2-restricted wild-type p53 epitope on the surface of human cancer cells30, the p5365-73 epitope may be a potent therapeutic target for Ad-p53 DC-induced p53-targeting CTLs in both mice and humans. This evidence concerns the gene TP53 and cancer.